HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Proposed Appropriation, Congress Tells FDA To Repurpose $7M For Cosmetic Regulation

Executive Summary

Proposed budget agreement by House and Senate leaders comes four days before funding ends under the latest continuing resolution to keep the federal government open and a week before the White House plans to release its FY2025 budget request.

You may also be interested in...



MoCRA Check-In: Abundance Of New Requirements, Enforcement Remains To Be Seen

EAS Consulting Group’s John Bailey continues to chronicle regulatory developments under the Modernization of Cosmetic Regulations Act. In this installment, he outlines industry stakeholders’ questions and concerns related to 2023 announcements from the US FDA and provisions of the law that became effective (if not yet enforced) at year-end.

Biden Administration's $7.13Bn FDA Budget Request For FY2025 Includes $3.3Bn In User Fees

White House’s 1,298-page budget request published on 11 March includes around $2m more than the agency’s total FY2024 spending Congress approved on 8 March and the president signed the next day. Of FDA’s total FY2025 spending $3.286bn would come from user fees.

Biden Administration Requests $7.13Bn FDA Budget For FY2025, Includes $3.3Bn In User Fees

The White House’s 1,298-page budget request published on 11 March includes around $2m more than the total for FY24, which Congress approved on 8 March and the president signed the next day. Of the FDA’s total FY2025 spending, $3.286bn would come from user fees.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154467

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel